Induction of cytotoxic T lymphocytes by dendritic cells pulsed with murine leukemic cell RNA. 2004

Chul Won Jung, and Jung Hye Kwon, and Jae Goo Seol, and Woo Hyun Park, and Jung Mi Hyun, and Eun Shil Kim, and Seung Taik Kim, and Sang Jae Lee, and Byoung Kook Kim, and Young Yiul Lee
Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Peptide-pulsed dendritic cells can stimulate T cells showing specific cytotoxicity in chronic myelogenous leukemia. We tried to induce a specific cytotoxic T-cell response stimulated by RNA-pulsed dendritic cells in acute myelogenous leukemia. The total RNA of WEHI-3BD+, a myelomonocytic leukemia cell line derived from BALB/c mice, was transfected into dendritic cells induced from bone marrow nucleated cells of BALB/c mice with granulocyte macrophage colony-stimulating factor (GM-CSF) and lipopolysaccharide (LPS) using liposome. RNA-pulsed dendritic cells were injected into the peritoneal cavity of BALB/c mice, and splenic T cells were isolated for antigen-stimulated proliferation and leukemia-specific cytotoxicity assay. Cultured bone marrow nucleated cells expressed dendritic cell markers including MHC class II antigen, CD80, CD86, and CD11c. T cells stimulated by RNA-pulsed dendritic cells showed enhanced proliferation than those stimulated by unpulsed dendritic cells (P = 0.05) and showed dose-dependent specific cytotoxicity against WEHI-3BD+ cells. We concluded total RNA-pulsed dendritic cells could induce a specific T-cell cytotoxicity in acute myelogenous leukemia.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D003713 Dendritic Cells Specialized cells of the hematopoietic system that have branch-like extensions. They are found throughout the lymphatic system, and in non-lymphoid tissues such as SKIN and the epithelia of the intestinal, respiratory, and reproductive tracts. They trap and process ANTIGENS, and present them to T-CELLS, thereby stimulating CELL-MEDIATED IMMUNITY. They are different from the non-hematopoietic FOLLICULAR DENDRITIC CELLS, which have a similar morphology and immune system function, but with respect to humoral immunity (ANTIBODY PRODUCTION). Dendritic Cells, Interdigitating,Interdigitating Cells,Plasmacytoid Dendritic Cells,Veiled Cells,Dendritic Cells, Interstitial,Dendritic Cells, Plasmacytoid,Interdigitating Dendritic Cells,Interstitial Dendritic Cells,Cell, Dendritic,Cell, Interdigitating,Cell, Interdigitating Dendritic,Cell, Interstitial Dendritic,Cell, Plasmacytoid Dendritic,Cell, Veiled,Cells, Dendritic,Cells, Interdigitating,Cells, Interdigitating Dendritic,Cells, Interstitial Dendritic,Cells, Plasmacytoid Dendritic,Cells, Veiled,Dendritic Cell,Dendritic Cell, Interdigitating,Dendritic Cell, Interstitial,Dendritic Cell, Plasmacytoid,Interdigitating Cell,Interdigitating Dendritic Cell,Interstitial Dendritic Cell,Plasmacytoid Dendritic Cell,Veiled Cell
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012334 RNA, Neoplasm RNA present in neoplastic tissue. Neoplasm RNA

Related Publications

Chul Won Jung, and Jung Hye Kwon, and Jae Goo Seol, and Woo Hyun Park, and Jung Mi Hyun, and Eun Shil Kim, and Seung Taik Kim, and Sang Jae Lee, and Byoung Kook Kim, and Young Yiul Lee
October 2006, Journal of clinical apheresis,
Chul Won Jung, and Jung Hye Kwon, and Jae Goo Seol, and Woo Hyun Park, and Jung Mi Hyun, and Eun Shil Kim, and Seung Taik Kim, and Sang Jae Lee, and Byoung Kook Kim, and Young Yiul Lee
December 2004, Leukemia research,
Chul Won Jung, and Jung Hye Kwon, and Jae Goo Seol, and Woo Hyun Park, and Jung Mi Hyun, and Eun Shil Kim, and Seung Taik Kim, and Sang Jae Lee, and Byoung Kook Kim, and Young Yiul Lee
December 2009, Journal of immunotoxicology,
Chul Won Jung, and Jung Hye Kwon, and Jae Goo Seol, and Woo Hyun Park, and Jung Mi Hyun, and Eun Shil Kim, and Seung Taik Kim, and Sang Jae Lee, and Byoung Kook Kim, and Young Yiul Lee
September 2000, Obstetrics and gynecology,
Chul Won Jung, and Jung Hye Kwon, and Jae Goo Seol, and Woo Hyun Park, and Jung Mi Hyun, and Eun Shil Kim, and Seung Taik Kim, and Sang Jae Lee, and Byoung Kook Kim, and Young Yiul Lee
August 1993, International immunology,
Chul Won Jung, and Jung Hye Kwon, and Jae Goo Seol, and Woo Hyun Park, and Jung Mi Hyun, and Eun Shil Kim, and Seung Taik Kim, and Sang Jae Lee, and Byoung Kook Kim, and Young Yiul Lee
May 2004, Leukemia research,
Chul Won Jung, and Jung Hye Kwon, and Jae Goo Seol, and Woo Hyun Park, and Jung Mi Hyun, and Eun Shil Kim, and Seung Taik Kim, and Sang Jae Lee, and Byoung Kook Kim, and Young Yiul Lee
January 1998, Journal of immunotherapy (Hagerstown, Md. : 1997),
Chul Won Jung, and Jung Hye Kwon, and Jae Goo Seol, and Woo Hyun Park, and Jung Mi Hyun, and Eun Shil Kim, and Seung Taik Kim, and Sang Jae Lee, and Byoung Kook Kim, and Young Yiul Lee
April 2002, Leukemia research,
Chul Won Jung, and Jung Hye Kwon, and Jae Goo Seol, and Woo Hyun Park, and Jung Mi Hyun, and Eun Shil Kim, and Seung Taik Kim, and Sang Jae Lee, and Byoung Kook Kim, and Young Yiul Lee
June 2004, American journal of respiratory and critical care medicine,
Chul Won Jung, and Jung Hye Kwon, and Jae Goo Seol, and Woo Hyun Park, and Jung Mi Hyun, and Eun Shil Kim, and Seung Taik Kim, and Sang Jae Lee, and Byoung Kook Kim, and Young Yiul Lee
November 2003, Chinese medical journal,
Copied contents to your clipboard!